Iovance Biotherapeutics Stock Forward View - Relative Strength Index
| IOVA Stock | USD 2.63 0.12 4.36% |
Iovance Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Iovance Biotherapeutics stock prices and determine the direction of Iovance Biotherapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Iovance Biotherapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
At this time, The value of RSI of Iovance Biotherapeutics' share price is at 53. This usually indicates that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Iovance Biotherapeutics, making its price go up or down. Momentum 53
Impartial
Oversold | Overbought |
Using Iovance Biotherapeutics hype-based prediction, you can estimate the value of Iovance Biotherapeutics from the perspective of Iovance Biotherapeutics response to recently generated media hype and the effects of current headlines on its competitors.
Iovance Biotherapeutics after-hype prediction price | USD 2.63 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Iovance Biotherapeutics to cross-verify your projections. Iovance Biotherapeutics Additional Predictive Modules
Most predictive techniques to examine Iovance price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Iovance using various technical indicators. When you analyze Iovance charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Relative Strength Index | Relative Strength Index | Trend |
| 53.74 | 53.74 |
| Check Iovance Biotherapeutics Volatility | Backtest Iovance Biotherapeutics | Information Ratio |
Iovance Biotherapeutics Trading Date Momentum
| On January 30 2026 Iovance Biotherapeutics was traded for 2.63 at the closing time. The top price for the day was 2.84 and the lowest listed price was 2.62 . There was no trading activity during the period 0.0. Lack of trading volume on January 30, 2026 did not cause price change. The trading delta at closing time against the current closing price is 4.56% . |
| Compare Iovance Biotherapeutics to competition |
Other Forecasting Options for Iovance Biotherapeutics
For every potential investor in Iovance, whether a beginner or expert, Iovance Biotherapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Iovance Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Iovance. Basic forecasting techniques help filter out the noise by identifying Iovance Biotherapeutics' price trends.Iovance Biotherapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Iovance Biotherapeutics stock to make a market-neutral strategy. Peer analysis of Iovance Biotherapeutics could also be used in its relative valuation, which is a method of valuing Iovance Biotherapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Iovance Biotherapeutics Market Strength Events
Market strength indicators help investors to evaluate how Iovance Biotherapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Iovance Biotherapeutics shares will generate the highest return on investment. By undertsting and applying Iovance Biotherapeutics stock market strength indicators, traders can identify Iovance Biotherapeutics entry and exit signals to maximize returns.
Iovance Biotherapeutics Risk Indicators
The analysis of Iovance Biotherapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Iovance Biotherapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting iovance stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.31 | |||
| Semi Deviation | 3.97 | |||
| Standard Deviation | 6.14 | |||
| Variance | 37.73 | |||
| Downside Variance | 18.57 | |||
| Semi Variance | 15.76 | |||
| Expected Short fall | (5.72) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Iovance Biotherapeutics
The number of cover stories for Iovance Biotherapeutics depends on current market conditions and Iovance Biotherapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Iovance Biotherapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Iovance Biotherapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Iovance Biotherapeutics Short Properties
Iovance Biotherapeutics' future price predictability will typically decrease when Iovance Biotherapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Iovance Biotherapeutics often depends not only on the future outlook of the potential Iovance Biotherapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Iovance Biotherapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 289.9 M | |
| Cash And Short Term Investments | 323.8 M |
Check out Historical Fundamental Analysis of Iovance Biotherapeutics to cross-verify your projections. For information on how to trade Iovance Stock refer to our How to Trade Iovance Stock guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Stock space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Iovance Biotherapeutics. Market participants price Iovance higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Iovance Biotherapeutics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding Iovance Biotherapeutics requires distinguishing between market price and book value, where the latter reflects Iovance's accounting equity. The concept of intrinsic value—what Iovance Biotherapeutics' is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Iovance Biotherapeutics' price substantially above or below its fundamental value.
Please note, there is a significant difference between Iovance Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Iovance Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Iovance Biotherapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.